SGLT2 inhibitors improve cardiac function by improving intracellular calcium availability and optimizing the cell shape of cardiac myocytes

Documenti analoghi

• Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes
  di: Marina Scardigli, et al.
  Pubblicazione: (2024)
• Advances in induced pluripotent stem cell‐derived cardiac myocytes: technological breakthroughs, key discoveries and new applications
  di: Colleen E. Clancy, et al.
  Pubblicazione: (2024)
• Hyperglycaemia‐induced reactive oxygen species production in cardiac ventricular myocytes differs among mammals
  di: Shan Lu, et al.
  Pubblicazione: (2025)
• RyR cooperativity and mobile buffers: functional clues to the resolution of the cardiac calcium wave problem?
  di: Michael A. Colman
  Pubblicazione: (2024)
• Mitochondrial oxidative stress, calcium and dynamics in cardiac ischaemia‐reperfusion injury
  di: Emily Rozich, et al.
  Pubblicazione: (2025)